Literature DB >> 12896981

Opposing roles of C/EBPbeta and AP-1 in the control of fibroblast proliferation and growth arrest-specific gene expression.

Mark Gagliardi1, Scott Maynard, Tetsuaki Miyake, Natalie Rodrigues, Sie Lung Tjew, Eric Cabannes, Pierre-Andre Bedard.   

Abstract

Chicken embryo fibroblasts (CEF) express several growth arrest-specific (GAS) gene products in G0. In contact-inhibited cells, the expression of the most abundant of these proteins, the p20K lipocalin, is activated at the transcriptional level by C/EBPbeta. In this report, we describe the role of C/EBPbeta in CEF proliferation. We show that the expression of a dominant negative mutant of C/EBPbeta (designated Delta184-C/EBPbeta) completely inhibited p20K expression at confluence and stimulated the proliferation of CEF without inducing transformation. Mouse embryo fibroblasts nullizygous for C/EBPbeta had a proliferative advantage over cells with one or two functional copies of this gene. C/EBP inhibition enhanced the expression of the three major components of AP-1 in cycling CEF, namely c-Jun, JunD, and Fra-2, and stimulated AP-1 activity. In contrast, the over-expression of C/EBPbeta caused a dramatic reduction in the levels of AP-1 proteins. Therefore, C/EBPbeta is a negative regulator of AP-1 expression and activity in CEF. The expression of cyclin D1 and cell proliferation were stimulated by the dominant negative mutant of C/EBPbeta but not in the presence of TAM67, a dominant negative mutant of c-Jun and AP-1. CEF over-expressing c-Jun, and to a lesser extent JunD and Fra-2, did not growth arrest at high cell density and did not express p20K. Therefore, AP-1 interfered with the action of C/EBPbeta at high cell density, indicating that these factors play opposing roles in the control of GAS gene expression and CEF proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12896981     DOI: 10.1074/jbc.M304085200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Pleiotropic action of AP-1 in v-Src-transformed cells.

Authors:  Lizhen Wang; Natalie A Rodrigues; Ying Wu; Bart M Maslikowski; Nishi Singh; Samantha Lacroix; Pierre-André Bédard
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

2.  Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer.

Authors:  Manisha Juneja; Katharina Ilm; Peter M Schlag; Ulrike Stein
Journal:  Mol Oncol       Date:  2013-06-06       Impact factor: 6.603

3.  JunD/AP-1 Antagonizes the Induction of DAPK1 To Promote the Survival of v-Src-Transformed Cells.

Authors:  Bart M Maślikowski; Lizhen Wang; Ying Wu; Ben Fielding; Pierre-André Bédard
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

4.  Extracellular Signal-Regulated Kinase 2 and CHOP Restrict the Expression of the Growth Arrest-Specific p20K Lipocalin Gene to G0.

Authors:  M J Erb; D Camacho; W Xie; B M Maslikowski; B Fielding; R Ghosh; F-A Poujade; M Athar; S Assee; L-E Mantella; P-A Bédard
Journal:  Mol Cell Biol       Date:  2016-11-14       Impact factor: 4.272

5.  CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.

Authors:  Romina Gutsch; Judith D Kandemir; Daniel Pietsch; Christian Cappello; Johann Meyer; Kathrin Simanowski; René Huber; Korbinian Brand
Journal:  J Biol Chem       Date:  2011-05-10       Impact factor: 5.157

6.  Role of C/EBPβ transcription factor in adult hippocampal neurogenesis.

Authors:  Marta Cortes-Canteli; Diana Aguilar-Morante; Marina Sanz-Sancristobal; Diego Megias; Angel Santos; Ana Perez-Castillo
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

7.  The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.

Authors:  Daniel R Carrasco; Kumar Sukhdeo; Marina Protopopova; Raktim Sinha; Miriam Enos; Daniel E Carrasco; Mei Zheng; Mala Mani; Joel Henderson; Geraldine S Pinkus; Nikhil Munshi; James Horner; Elena V Ivanova; Alexei Protopopov; Kenneth C Anderson; Giovanni Tonon; Ronald A DePinho
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.